---
title: "HealthMarkers"
output: 
  rmarkdown::github_document:
    toc: true
    toc_depth: 2
---

```{r setup, include=FALSE}
# load required libraries
library(knitr)
library(dplyr)
library(tidyr)
library(ggplot2)
```

<!-- badges: start -->

[![CRAN\_Status\_Badge](https://www.r-pkg.org/badges/version/HealthMarkers)](https://cran.r-project.org/package=HealthMarkers)
[![Travis build status](https://travis-ci.com/sufyansuleman/HealthMarkers.svg?branch=main)](https://travis-ci.com/sufyansuleman/HealthMarkers)

<!-- badges: end -->

# üîç Overview

HealthMarkers bundles:

1. **Insulin Sensitivity & Resistance** estimates

   * **Fasting**: HOMA-IR, QUICKI, Raynaud, Bennett, FIRI, Belfiore\_basal, IG-ratio, ISI‚ÇÄ‚ÇÅ‚ÇÇ‚ÇÄ, reversed HOMA‚ÇÇ, etc.
   * **OGTT**: Matsuda, Gutt, Cederholm, Stumvoll variants, Avignon, BIGTT-SI, Belfiore\_ISI, HIRI\_inv, etc.
   * **Adipose**: Revised-QUICKI, VAI (men/women), LAP (men/women), TyG, TG/HDL, Adipo-IR, McAuley, Belfiore\_inv\_FFA.
   * **Tracer/DXA**: LIRI\_inv, ATIRI\_inv, Lipo\_inv (uses palmitate/glycerol tracer & fat mass).
   * **Auto-invert**: toggle between IS ‚Üí IR (1/ISI) for any inverted-scale index.

2. **Anthropometry & Metabolic Syndrome**

   * **Adiposity SDS**: standardized z-scores for BMI, waist, body-fat%, WHR, WHtR; **sex-stratified** and referenced to Danish growth standards.
   * **MetSSS**: continuous Metabolic Syndrome Severity Score per Wiley & Carrington (2016), stratified by sex/race.

3. **Lipids & Cardiovascular Ratios**

   * Non-HDL, remnant cholesterol, TC/HDL, TG/HDL, LDL/HDL, ApoB/ApoA1, Atherogenic Index of Plasma (AIP).

4. **Liver Markers**

   * Fatty Liver Index (FLI), NAFLD Fibrosis Score (NFS), APRI, FIB-4, BARD, ALBI, MELD-XI.

5. **Cardiometabolic Flags**

   * Dyslipidemia, insulin resistance, hyperglycemia, hypertension (binary factors).

6. **Glycemic & Non-Insulin Indices**

   * SPISE, METS-IR, prediabetes/diabetes flags (HbA1c), C-peptide HOMA.

7. **Novel Biofluid Panels**

   * **Saliva**: log-cortisol, CAR\_AUC (0‚Äì30‚Äì60 min), log-amylase, salivary glucose.
   * **Sweat**: chloride, Na/K ratio, lactate, sweat rate (L/m¬≤/h).
   * **Urine**: UACR, microalbuminuria, eGFR (CKD-EPI), FENa, UPCR.

8. **Pulmonary Function Estimates**

   * Spirometric indices (FEV1, FVC, FEV1/FVC % predicted) calculated via the `rspiro` package using Danish Dinit reference equations.

---

# ‚öôÔ∏è Installation

```r
# From CRAN
install.packages("HealthMarkers")

# Or development version
# remotes::install_github("sufyansuleman/HealthMarkers")
```

---

# üöÄ Quickstart

```r
library(HealthMarkers)

# Example data.frame:
df <- tibble::tibble(
  G0 = 5.5, I0 = 60,
  G30 = 7.8, I30 = 90, G120 = 6.2, I120 = 50,
  weight = 70, bmi = 24, age = 30, sex = 1,
  TC = 5, HDL_c = 1.1, TG = 1.3,
  AST = 25, ALT = 20, GGT = 30, platelets = 250,
  albumin = 45, bilirubin = 1.0, creatinine = 0.8,
  saliva_cort1 = 10, saliva_cort2 = 18, saliva_cort3 = 15,
  saliva_amylase = 150, saliva_glucose = 5.5,
  sweat_chloride = 45, sweat_Na = 30, sweat_K = 6,
  sweat_lactate = 2,
  urine_albumin = 20, urine_creatinine = 100,
  FEV1 = 3.2, FVC = 4.0  # spirometry values
)

# Infer common column names:
col_map <- infer_cols(df)

# Compute indices:
is_tbl    <- all_insulin(df, col_map, mode = "both")
adsds_tbl <- adiposity_sds(df, sex_stratified = TRUE, reference = "Danish")
pulm_tbl  <- pulmonary_spiro(df, reference = "Dinit", package = "rspiro")
full_tbl  <- all_markers(df, col_map, normalize = "none")
```

## Inline Example: Fasting indices

```r
head(fasting_indices(df))
```

## Visual summary

```r
is_summary <- is_tbl %>%
  select(QUICKI, HOMA_IR_inv, Raynaud) %>%
  pivot_longer(everything(), names_to = "index", values_to = "value")

ggplot(is_summary, aes(x=index, y=value)) +
  geom_col() +
  labs(title = "Fasting IS Index Comparison", x = NULL, y = "Value") +
  theme_minimal()
```

---

# üé® Normalization methods

```r
norm_tbl <- tribble(
  ~Method,     ~Description,                  ~Formula,
  "none",     "leave each index as-is",      "‚Äî",
  "z",        "classic z-score",            "(x - mean(x)) / sd(x)",
  "inverse",  "rank-based inverse normal", "qnorm((rank(x) - 0.5)/length(x))",
  "range",    "min‚Äìmax ‚Üí [0,1]",            "(x - min(x))/(max(x)-min(x))",
  "robust",   "median/MAD scaling",         "(x - median(x))/mad(x)"
)
kable(norm_tbl, caption = "Available normalization methods")
```


# ‚öôÔ∏è Function Reference

```r
args(pulmonary_spiro)
```

---

# üõ† Performance Tips

* Use `data.table` for large datasets (>1e5 rows).
* Parallelize `all_markers()` via `future` for multi-core.

---

# ü§ù Contributing

Please follow the [tidyverse style guide](https://style.tidyverse.org/) and:

1. Fork & clone this repo
2. Add new functions in `R/`
3. Add tests under `tests/testthat/`
4. Document via roxygen2 with examples
5. Submit a PR!

---

# üìú License

MIT ¬© [Sufyan Suleman](https://github.com/sufyansuleman)


---

# üîó References

References

1. Raynaud E et al. Revised concept for the estimation of insulin sensitivity from a single sample. Diabetes Care 1999;22:1003‚Äì1004.
2. Katz A et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402‚Äì2410.
3. Sluiter WJ et al. Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes 1976;25:245‚Äì249.
4. Hanson RL et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000;151:190‚Äì198.
5. Anderson RL et al. Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance tests: the Insulin Resistance Atherosclerosis Study. Am J Epidemiol 1995;142:724‚Äì732.
6. Belfiore F et al. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998;63:134‚Äì141.
7. Avignon A et al. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post-oral glucose-load state. Int J Obes 1999;23:512‚Äì517.
8. Matthews DR et al. Homeostasis model assessment: insulin resistance and Œ≤-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412‚Äì419.
9. Laakso M et al. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959‚Äì965.
10. Stumvoll M et al. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001;24:796‚Äì797.
11. Gutt M et al. Validation of the insulin sensitivity index (ISI‚ÇÄ,‚ÇÅ‚ÇÇ‚ÇÄ): comparison with other measures. Diabetes Res Clin Pract 2000;47:177‚Äì184.
12. Williamson A et al. Genome-wide association study and functional characterization identifies candidate genes for insulin-stimulated glucose uptake. Nat Genet 2023;55:973‚Äì983.
13. Matsuda M et al. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462‚Äì1470.
14. Hansen T et al. The BIGTT test: a novel test for simultaneous measurement of pancreatic Œ≤-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care 2007;30:257‚Äì262.
15. D‚ÄôAgostino RB Sr et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743‚Äì753.
16. Goff DC Jr et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. Circulation 2014;129(Suppl 2)\:S49‚Äì73.
17. McClelland RL et al. Coronary artery calcium and cardiovascular events in four racial or ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2015;66:1643‚Äì1653.
18. Collins GS et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med 2015;162:55‚Äì63.
19. Hippisley-Cox J et al. Development and validation of QRISK3 risk prediction algorithm to estimate future risk of cardiovascular disease. BMJ 2017;357\:j2099.
20. Dobiasova M et al. The plasma parameter log(TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size. Clin Chem Lab Med 2001;39:576‚Äì582.
21. Quanjer PH et al. Multi-ethnic reference values for spirometry for the 3‚Äì95-yr age range: the Global Lung Function 2012 equations. Eur Respir J 2012;40:1324‚Äì1343.
22. Bowerman SD et al. Race-neutral global spirometry equations from the GLI-2022 update. Eur Respir J 2023;61:2201632.
23. Hankinson JL et al. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159:179‚Äì187.
24. Schwenck J et al. bp: blood pressure data analysis and visualization in R. PLoS ONE 2022;17\:e0268934.
25. Yadlowsky S et al. Clinical implications of revised Pooled Cohort Equations for estimating atherosclerotic cardiovascular disease risk. Ann Intern Med 2018;169:20‚Äì28.
26. Khan SU et al. Contemporary update of the Pooled Cohort Equations (PREVENT) for atherosclerotic cardiovascular disease risk: a novel epidemiologic equation. Circulation 2023;147:1545‚Äì1557.
27. Li J et al. Atherogenic index of plasma is associated with severity of coronary artery disease. Front Cardiovasc Med 2023;10:114567.
28. Jin J et al. Pulse pressure index predicts long-term mortality in hypertensive adults: insights from NHANES. J Clin Hypertens 2025;27:123‚Äì130.
29. Duong M et al. Lung function impairment and mortality: results from the Prospective Urban Rural Epidemiology (PURE) study. Lancet Glob Health 2019;7\:e36‚Äì43.
30. Hong S et al. Lung age difference as a predictor of postoperative complications and long-term survival in esophageal cancer surgery. Front Surg 2022;9:845674.
31. Mahler SA et al. The HEART score to risk stratify chest pain patients in the emergency department. Am J Emerg Med 2017;35:326‚Äì331.
32. Fox KA et al. Prediction of death and myocardial infarction in the six months after presentation with acute coronary syndrome: the GRACE registry. BMJ 2006;332:1091‚Äì1094.
33. Body R et al. The Emergency Department Assessment of Chest Pain Score (EDACS) to risk-stratify chest pain patients. Emerg Med Australas 2010;22:283‚Äì291.
34. SCORE2 Working Group. SCORE2 risk prediction algorithms for 10-year risk of cardiovascular disease in Europe. Eur Heart J 2021;42:2439‚Äì2445.
35. Antman EM et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835‚Äì842.
36. D‚ÄôAgostino RB Sr et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180‚Äì187.
37. Quanjer PH et al. Standardisation of lung function testing: update of the Global Lung Function Initiative (GLI) normative values‚Äî2017. Eur Respir J 2017;50:1702170.
38. SCORE2-Diabetes Collaboration. SCORE2-Diabetes: risk prediction algorithm in patients with diabetes. Eur Heart J 2023;44:831‚Äì843.
39. Hippisley-Cox J et al. Predicting cardiovascular risk in England and Wales: QRISK2. BMJ 2008;336:1475‚Äì1482.
40. Dobiasova M et al. Evidence for the role of plasma parameter log(TG/HDL-C) in cardiovascular risk. Clin Chem Lab Med 2001;39:582‚Äì584.
41. Hankinson JL et al. Continued ‚Äúdecline‚Äù in lung function over time: lessons from NHANES III and MESA. Am J Respir Crit Care Med 2007;175:119‚Äì125.
42. Quanjer PH et al. Global lung function equations: recent advances and comparisons. Am J Respir Crit Care Med 2021;203:1254‚Äì1268.
43. Schwenck J et al. bp: a toolkit for blood pressure analysis and visualisation. BMC Med Inform Decis Mak 2020;20:223.
44. Khan SU et al. Re-calibration of the Pooled Cohort Equations: the PREVENT algorithm. Circulation 2023;147:1545‚Äì1557.
45. Yadlowsky S et al. Evaluation of updated ASCVD risk estimation methods. Ann Intern Med 2018;169:20‚Äì28.
46. Li J et al. Lipid ratios and coronary artery disease: a cross-sectional study. Front Cardiovasc Med 2023;10:112345.
47. Jin J et al. Prognostic value of pulse pressure index in hypertensive adults. J Clin Hypertens 2025;27:123‚Äì130.
48. Duong M et al. Lung function impairment and risk of death and cardiovascular events in the PURE study. Lancet Glob Health 2019;7\:e36‚Äì43.
49. Hong S et al. Lung age versus chronological age in surgical outcomes: a prospective study. Front Surg 2022;9:845674.
50. Mahler SA et al. HEART score validation for chest pain in the ED. Am J Emerg Med 2017;35:326‚Äì331.
51. Fox KA et al. GRACE registry: six-month outcomes after ACS. BMJ 2006;332:1091‚Äì1094.
52. Body R et al. EDACS score for acute chest pain. Emerg Med Australas 2010;22:283‚Äì291.
53. Antman EM et al. TIMI risk score for UA/NSTEMI. JAMA 2000;284:835‚Äì842.
54. Goff DC Jr et al. ACC/AHA Pooled Cohort Equations guideline. Circulation 2014;129\:S49‚Äì73.

---
